These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 23415567

  • 1. Hypothermia for acute ischaemic stroke.
    Wu TC, Grotta JC.
    Lancet Neurol; 2013 Mar; 12(3):275-84. PubMed ID: 23415567
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic hypothermia for acute ischemic stroke.
    Froehler MT, Ovbiagele B.
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):593-603. PubMed ID: 20397832
    [Abstract] [Full Text] [Related]

  • 3. [Reperfusion in acute ischaemic stroke: present and future].
    Herrera M, Gállego J, Muñoz R, Aymerich N, Zandio B.
    An Sist Sanit Navar; 2008 Apr; 31 Suppl 1():31-46. PubMed ID: 18528442
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolytic treatment for acute ischaemic stroke.
    Mazumdar A, Derdeyn CP.
    Expert Opin Pharmacother; 2006 Feb; 7(3):287-96. PubMed ID: 16448323
    [Abstract] [Full Text] [Related]

  • 5. Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.
    Jones ML, Holmes M.
    Health Technol Assess; 2009 Sep; 13 Suppl 2():15-21. PubMed ID: 19804685
    [Abstract] [Full Text] [Related]

  • 6. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [Abstract] [Full Text] [Related]

  • 7. Acute ischemic stroke update.
    Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S.
    Pharmacotherapy; 2010 May; 30(5):493-514. PubMed ID: 20412000
    [Abstract] [Full Text] [Related]

  • 8. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A, Krass I, Bajorek BV.
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [Abstract] [Full Text] [Related]

  • 9. Sonothrombolysis for the treatment of acute stroke: current concepts and future directions.
    Amaral-Silva A, Piñeiro S, Molina CA.
    Expert Rev Neurother; 2011 Feb; 11(2):265-73. PubMed ID: 21306213
    [Abstract] [Full Text] [Related]

  • 10. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.
    Amlie-Lefond C, deVeber G, Chan AK, Benedict S, Bernard T, Carpenter J, Dowling MM, Fullerton H, Hovinga C, Kirton A, Lo W, Zamel K, Ichord R, International Pediatric Stroke Study.
    Lancet Neurol; 2009 Jun; 8(6):530-6. PubMed ID: 19423401
    [Abstract] [Full Text] [Related]

  • 11. Acute Care of Ischemic Stroke Patients in the Hospital.
    Meisel KM, Thabet AM, Josephson SA.
    Semin Neurol; 2015 Dec; 35(6):629-37. PubMed ID: 26595863
    [Abstract] [Full Text] [Related]

  • 12. Specific therapies for ischaemic stroke: rTPA and others.
    Toni D, Lorenzano S, Sacchetti ML, Fiorelli M, De Michele M, Principe M.
    Neurol Sci; 2005 May; 26 Suppl 1():S26-8. PubMed ID: 15883686
    [Abstract] [Full Text] [Related]

  • 13. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [Abstract] [Full Text] [Related]

  • 14. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R.
    Lancet; 2014 Aug 23; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract] [Full Text] [Related]

  • 15. Alteplase not yet proven for acute ischaemic stroke.
    Bath P.
    Lancet; 1998 Oct 17; 352(9136):1238-9. PubMed ID: 9788448
    [No Abstract] [Full Text] [Related]

  • 16. Ischemic stroke: emergencies and management.
    Kelley RE, Martin-Schild S.
    Neurol Clin; 2012 Feb 17; 30(1):187-210, ix. PubMed ID: 22284060
    [Abstract] [Full Text] [Related]

  • 17. Endovascular treatment strategies for acute ischemic stroke.
    Ellis JA, Youngerman BE, Higashida RT, Altschul D, Meyers PM.
    Int J Stroke; 2011 Dec 17; 6(6):511-22. PubMed ID: 22111796
    [Abstract] [Full Text] [Related]

  • 18. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD, Hjort N, Zeidler D, Sørensen L, Nørgaard A, Thomsen RB, Jonsdottir K, Mouridsen K, Hansen TM, Cho TH, Nielsen TT, Bøtker HE, Østergaard L, Andersen G.
    Int J Stroke; 2013 Feb 17; 8(2):141-6. PubMed ID: 22463392
    [Abstract] [Full Text] [Related]

  • 19. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E, Chamorro A, Dávalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W.
    Lancet Neurol; 2009 Dec 17; 8(12):1095-102. PubMed ID: 19850525
    [Abstract] [Full Text] [Related]

  • 20. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM, Sandercock PA, Murray V.
    BMJ; 2009 Nov 11; 339():b4584. PubMed ID: 19906748
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.